Text Size
A A A
Skip Navigation

Home > RePORTER > Project Information

Project InformationProject Information Help

Project Number: 5R01CA070759-12 Contact PI / Project Leader: FRAZIER, MARSHA L.
Title: MOLECULAR GENETICS OF HNPCC Awardee Organization: UT MD ANDERSON CANCER CTR
Description
Abstract Text:
DESCRIPTION (provided by applicant): The overall goal of this application is to elucidate genetic risk modifiers influencing age of onset of hereditary nonpolyposis colorectal cancer (HNPCC) using a pathway-based approach. The overall hypothesis of this proposal is that SNPs in cell cycle pathways influence the efficiency of the finely tuned mechanisms of cell cycle progression. We will continue to build and expand upon our unique clinical and specimen resource of mismatch repair gene mutation carriers in order to accomplish this goal. In aim 1, we will determine the role that genetic variants in cell cycle genes have on risk for development of early onset HNPCC. We will use the Illumina Golden Gate platform to genotype SNPs from 153 cell cycle genes. We will evaluate the main effects of SNPs in these genes using a two-phase study design in order to determine if there are differences in age-associated risk for development of HNPCC between carriers of the wild type genotype vs. those carrying one or two copies of the SNP. In aim 2, we will use novel machine learning analytic tools to determine if we can identify combinations of cell cycle SNPs that work together to influence risk for development of early onset HNPCC. Two approaches will be used to accomplish this goal. A focused candidate gene approach, and the second is an exploratory, pathways based approach. In the focused candidate approach, we have selected 12 candidate genes because they are known to interact with each other in the cell cycle pathways and there is evidence that SNPs in these genes influence risk for HNPCC or other cancers. We will determine if combinations of these SNPs work together to influence development of HNPCC at an early age. In the second approach we will investigate SNPs in all 153 of the genes, including the 12 candidate genes. We hypothesize that there are many possible combinations of cell cycle genes that work together and under the influence of SNPS, contribute to development of HNPCC at an early age. We will use Random Forests (RF) modeling to rank all of the SNPs from these genes. RF can handle large numbers of predictor variables such as SNPs and provides estimates of variable importance. We will then use CART to build age-to-onset trees using the SNPs ranked the highest from RF. The proposed studies will contribute to our long-term goal to develop a risk model for early onset HNPCC by defining the role that SNPs in cell cycle genes play in risk for HNPCC. They will also provide important information regarding novel gene-gene interactions contributing to risk for development of HNPCC at an earlier age. The National Cancer Institute in its 2006 budget proposal cited risk prediction as an area of extraordinary opportunity. Risk prediction models for cancer could provide valuable tools for identifying individuals who may benefit from preventive treatments or increased surveillance or who are good candidates to participate in clinical trials. PUBLIC HEALTH REVELANCE: The proposed studies will contribute to our long-term goal to develop a risk model for HNPCC, which may also have important implications for sporadic colorectal cancer as well as other cancer sites.
NIH Spending Category:
Biotechnology; Cancer; Clinical Research; Colo-Rectal Cancer; Digestive Diseases; Genetic Testing; Genetics; Rare Diseases
Project Terms:
Abbreviations; Age; Age of Onset; Area; Aspirin; aurora-A kinase; base; Base Excision Repairs; Budgets; Cancer Model; cancer site; Candidate Disease Gene; cdc Genes; CDK4 gene; Cell Cycle; Cell Cycle Checkpoint; Cell Cycle Progression; Cells; CHEK2 gene; Classification; Clinical; Clinical Trials; Colorectal Cancer; Complex; Cyclin D1; Data; Databases; Defect; Development; Disease; Early Diagnosis; early onset; Ethnicity aspects; forest; Foundations; Gender; gene interaction; Gene Mutation; Gene Order; Genes; Genetic Polymorphism; Genetic Risk; genetic variant; Genome; Genotype; Germ-Line Mutation; Goals; Health; Hereditary Nonpolyposis Colorectal Neoplasms; homologous recombination; Individual; Large Intestine Carcinoma; Learning; Leukocytes; Linkage Disequilibrium; Machine Learning; Maintenance; Malignant Neoplasms; MDM2 gene; Mediating; Microsatellite Instability; Mismatch Repair; Modeling; Molecular Genetics; Mutate; mutation carrier; National Cancer Institute; Nonhomologous DNA End Joining; novel; Nucleotide Excision Repair; Obesity; Pathway interactions; peripheral blood; Phase; Play; Preventive; protein protein interaction; Proteolysis; Research Design; Resources; Risk; Role; Single Nucleotide Polymorphism; Smoking; Specimen; STK6 gene; Techniques; Testing; tool; Trees; Ubiquitination; Validation; Work



The RePORTER database is available to all public users at http://exporter.nih.gov/. As the data are available for bulk download, the RePORTER system reserves the right to block IP addresses that fail to adhere to instructions in the system’s robots.txt files or submit requests at a rate that negatively impacts service delivery to other users. RePORTER reserves the right to terminate any automated query to the RePORTER application that negatively affects service delivery to other users.

Page Last Updated on March 18, 2013
This site is best viewed with Internet Explorer (7.0 or higher) or Mozilla Firefox (3.0).

NIH...Turning Discovery Into Health®
RePORTERE3